Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, September 8, 2017
[ Fri, Sep 08th 2017
] - WOPRAI
[ Fri, Sep 08th 2017
] - WOPRAI
[ Fri, Sep 08th 2017
] - WOPRAI
[ Fri, Sep 08th 2017
] - WOPRAI
[ Fri, Sep 08th 2017
] - WOPRAI
[ Fri, Sep 08th 2017
] - WOPRAI
[ Fri, Sep 08th 2017
] - WOPRAI
[ Fri, Sep 08th 2017
] - WOPRAI
[ Fri, Sep 08th 2017
] - WOPRAI
[ Fri, Sep 08th 2017
] - WOPRAI
[ Fri, Sep 08th 2017
] - WOPRAI
[ Fri, Sep 08th 2017
] - WOPRAI
[ Fri, Sep 08th 2017
] - WOPRAI
Thu, September 7, 2017
[ Thu, Sep 07th 2017
] - WOPRAI
[ Thu, Sep 07th 2017
] - WOPRAI
[ Thu, Sep 07th 2017
] - WOPRAI
[ Thu, Sep 07th 2017
] - WOPRAI
[ Thu, Sep 07th 2017
] - WOPRAI
[ Thu, Sep 07th 2017
] - WOPRAI
[ Thu, Sep 07th 2017
] - WOPRAI
[ Thu, Sep 07th 2017
] - WOPRAI
[ Thu, Sep 07th 2017
] - WOPRAI
[ Thu, Sep 07th 2017
] - WOPRAI
[ Thu, Sep 07th 2017
] - WOPRAI
[ Thu, Sep 07th 2017
] - WOPRAI
Alex Arfaei Initiated (AZN) at Buy and Held Target at $38 on, Sep 7th, 2017
Published on 2024-10-25 22:40:24 -
Alex Arfaei of BMO Capital, Initiated "AstraZeneca PLC" (AZN) at Buy and Held Target at $38 on, Sep 7th, 2017.
Alex has made no other calls on AZN in the last 4 months.
There are 2 other peers that have a rating on AZN. Out of the 2 peers that are also analyzing AZN, all agree with Alex's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Seamus Fernandez of "Leerink Swann" Downgraded from Buy to Hold on, Thursday, July 27th, 2017
- Rebekah Harper of "Credit Suisse" Upgraded from Sell to Hold on, Monday, May 15th, 2017